Phase II trial of pentostatin in refractory lymphomas and cutaneous T-cell disease.
F J Cummings(Brown University), M. J. OʼConnell(Mayo Clinic in Arizona), Risa B. Mann(Boston University), Richard S. Neiman(University Medical Center), Sigmund A. Weitzman(Palmetto Hematology Oncology), Robert L. Comis(Fox Chase Cancer Center), M. M. Oken(University of Minnesota), Ki Wook Kim(Catholic University of Korea)
Cited by 90
Related Papers
Comparison of a Second-Generation Combination Chemotherapeutic Regimen (m-BACOD) with a Standard Regimen (CHOP) for Advanced Diffuse Non-Hodgkin's Lymphoma
|New England Journal of Medicine|1992|326
Detection of ebv gene expression in reed‐sternberg cells of Hodgkin's disease
|International Journal of Cancer|1990|282
Immunoperoxidase Technics in Diagnostic Pathology: Report of a Workshop Sponsored by the National Cancer Institute
|American Journal of Clinical Pathology|1979|264